Differential expression of major histocompatibility complex class Ia, Ib and II molecules on monocytes and monocyte-derived dendritic and macrophagic cells
- 31 July 1999
- journal article
- Published by Elsevier in Human Immunology
- Vol. 60 (7) , 591-597
- https://doi.org/10.1016/s0198-8859(99)00025-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon γ and lipopolysaccharideCancer Immunology, Immunotherapy, 1997
- Human monocyte‐derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I‐restricted exogenous peptidesImmunology, 1997
- Differentiation of human dendritic cells from monocytes in vitroEuropean Journal of Immunology, 1997
- Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsNature Medicine, 1996
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.The Journal of Experimental Medicine, 1996
- The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP associationImmunity, 1995
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- Cellular immune recognition of HLA-G-expressing choriocarcinoma cell line JEG-3International Journal of Cancer, 1991
- Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodiesJournal of Immunological Methods, 1985